Syncom Formulations (India) Ltd

NSE: SYNCOMF BSE: 524470

₹13.24

(-2.58%)

Thu, 19 Feb 2026, 07:19 am

MTF 5xInvest in Syncom Formulations (India) Ltd with 5x Leverage Buy with MTF

Market Cap12.88B

PE Ratio18.05

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Syncom Formulations (India) Ltd About

Syncom Formulations (India) is a renowned name in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency. Currently Syncom manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1988

Headquarters

CEO

ANKIT KEDARMAL BANKDA

Employees

Contact

Website

http://www.syncomformulations.com

finance@sfil.in; sfil87@syncomformulations.com

Phone

91-22-30887744

Location

7 Niraj Indl Estate Andheri(E), Off Mahakali Caves Rd, Mumbai, Maharashtra, 400093

Executives

Kedarmal Bankda

Chairman & Exec. Director

Vijay Bankda

ED / MD / Promoter

Ruchi Jindal

Independent Non Exe. Director

Ritesh Kumar Lunkad

Independent Non Exe. Director

Ankit Jain

Independent Non Exe. Director

ANKIT KEDARMAL BANKDA

Chairman / Executive Director / WTD

Vaishali Agrawal

Company Sec. & Compli. Officer

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800